EGFR and lung carcinoma: The EGFR-activating mutations are present in a subset of central nervous system tumours and lung cancer (Giaccone, 2005; Hynes and Lane, 2005), but are remarkably rare in breast cancer cell lines and human breast cancer samples (Bhargava et al, 2005).